Company Filing History:
Years Active: 2025
Title: M Eric Christy: Innovator in Proton Computed Tomography
Introduction
M Eric Christy is a notable inventor based in Seaford, Virginia, recognized for his contributions to the field of medical imaging. He has developed innovative technologies that enhance the capabilities of proton therapy treatment centers. His work focuses on utilizing proton beams for advanced imaging techniques, which are crucial for treatment planning and validation.
Latest Patents
One of Christy's significant patents is titled "Proton computed tomography using multichannel gas detection technology." This invention describes a Proton Computed Tomography (pCT) system that employs proton beams to create three-dimensional density maps of both test phantoms and living tissue. The pCT system is designed to provide in situ imaging with the same beam used for treatment, making it a highly sought-after modality in proton therapy. The system incorporates gaseous detectors for tracking and energy reconstruction, a shutter system to enhance dynamic range features while maintaining energy resolution, and a method for determining proton energy through a forward-search algorithm that utilizes segmentation of energy detector ionization signal readout. The gaseous detectors used in this system are based on Gas Electron Multiplier (GEM) technology.
Career Highlights
M Eric Christy is affiliated with Jefferson Science Associates, LLC, where he continues to advance research in proton therapy and imaging technologies. His work has significantly impacted the field, providing new methods for improving treatment accuracy and patient outcomes.
Collaborations
Christy collaborates with various professionals in the field, including his coworker Cynthia Keppel, to further enhance the development and application of his inventions.
Conclusion
M Eric Christy's innovative work in proton computed tomography exemplifies the intersection of technology and healthcare. His contributions are paving the way for improved imaging techniques in proton therapy, ultimately benefiting patient care and treatment efficacy.